Taro Pharmaceutical Industries (NYSE: TARO)
Taro Pharmaceutical Industries Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Taro Pharmaceutical Industries Company Info
Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.
News & Analysis
Why Shares of Taro Pharmaceutical Are Rising Tuesday
The company is mulling a buyout offer from Sun Pharmaceutical.
Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical Stocks
Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.
3 Cheap Growth Stocks You Can Buy Right Now
These three growth stocks are cheap now, but they might not stay cheap for much longer.
Why Taro Pharmaceutical Is Poised to Keep Popping
Market-trouncing returns could be written in this 4-Star.
Taro Calls Off Merger With Sun
Shareholders will no longer have to accept a 24% haircut on their shares.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.